"Acromegaly" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)
| Descriptor ID |
D000172
|
| MeSH Number(s) |
C05.116.132.082 C10.228.140.617.738.250.100 C19.700.355.179
|
| Concept/Terms |
Acromegaly- Acromegaly
- Somatotropin Hypersecretion Syndrome (Acromegaly)
- Hypersecretion Syndrome, Somatotropin (Acromegaly)
- Hypersecretion Syndromes, Somatotropin (Acromegaly)
- Somatotropin Hypersecretion Syndromes (Acromegaly)
- Syndrome, Somatotropin Hypersecretion (Acromegaly)
- Syndromes, Somatotropin Hypersecretion (Acromegaly)
- Inappropriate GH Secretion Syndrome (Acromegaly)
- Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)
|
Below are MeSH descriptors whose meaning is more general than "Acromegaly".
Below are MeSH descriptors whose meaning is more specific than "Acromegaly".
This graph shows the total number of publications written about "Acromegaly" by people in this website by year, and whether "Acromegaly" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 12 | 0 | 12 |
| 2018 | 7 | 1 | 8 |
| 2019 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Acromegaly" by people in Profiles.
-
Severe respiratory failure in a patient with COVID-19 and acromegaly: rapid improvement after adding octreotide. BMJ Case Rep. 2021 Aug 17; 14(8).
-
[New developments and perspectives in acromegaly]. Dtsch Med Wochenschr. 2021 Aug; 146(15):950-954.
-
Acromegaly Management in a Tertiary Referral Center After 1 Year of the Coronavirus 2019 Pandemic: A Double Challenge. Endocr Pract. 2021 Aug; 27(8):856-857.
-
Implementation and Monitoring of a Telemedicine Model in Acromegalic Outpatients in a Low-Income Country During the COVID-19 Pandemic. Telemed J E Health. 2021 08; 27(8):905-914.
-
Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing's disease. Pituitary. 2021 Aug; 24(4):589-599.
-
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era. Endocrine. 2021 02; 71(2):273-280.
-
Reply to letter to the editor: "COVID-19 and the endocrine system: exploring the unexplored". Focus on acromegaly. J Endocrinol Invest. 2021 03; 44(3):639-640.
-
Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis. Growth Horm IGF Res. 2021 02; 56:101363.
-
Letter to the Editor: "COVID-19 and the endocrine system: exploring the unexplored". Focus on acromegaly. J Endocrinol Invest. 2021 03; 44(3):637-638.
-
Deep-Learning Approach to Automatic Identification of Facial Anomalies in Endocrine Disorders. Neuroendocrinology. 2020; 110(5):328-337.